Our hosting provider will be performing UPS maintenance on Tuesday, Oct 25, 2016 between 8 AM and 5 PM PDT. SciCrunch searching services will be down during this time.

Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1.


We have previously shown that all six members of the anti-apoptotic BCL2 gene family can cooperate with (myelocytomatosis oncogene) MYC in a mouse model of leukemia, but three of them are significantly less potent contributors to leukemogenicity than the other three. The protein encoded by one of these less potent genes, BCL2L10/BCLb, was recently shown to vary dramatically in many primary human cancers by immunohistochemistry, and the protein levels were inversely correlated with survival in patients with several cancer types. We examined BCLb mRNA in a panel of human cancer cell lines and did not observe the extensive variation in mRNA that would be required to explain the vast differences in protein levels. We found that the levels of BCLb protein diminish quickly after inhibition of protein synthesis with cycloheximide, so we searched for interacting proteins that might affect posttranslational stability of BCLb. Using a variety of approaches, including immunoaffinity and mass spectrometry, we identified a protein, Ubiquilin1 (Ubqln), that specifically interacts with BCLb, and not with other anti-apoptotic BCL2-like proteins. Ubqln stabilizes BCLb protein, while also promoting monoubiquitination on multiple lysine residues and relocation to the cytosol. Furthermore, primary lung adencarcinomas have more Ubqln mRNA than normal adjacent lung tissue, and higher Ubqln mRNA levels are associated with shorter survival of lung cancer patients, suggesting that potentiation of the anti-apoptotic potential of BCLb through regulation of its stability by Ubqln may be an important factor in tumor progression.

Pubmed ID: 22233804


  • Beverly LJ
  • Lockwood WW
  • Shah PP
  • Erdjument-Bromage H
  • Varmus H


Proceedings of the National Academy of Sciences of the United States of America

Publication Data

January 17, 2012

Associated Grants

  • Agency: NCI NIH HHS, Id: P01 2P01CA094060-06A1
  • Agency: NCI NIH HHS, Id: P30 CA08748
  • Agency: Intramural NIH HHS, Id:

Mesh Terms

  • Adenocarcinoma
  • Animals
  • Apoptosis
  • Carrier Proteins
  • Cell Cycle Proteins
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic
  • Cytoplasm
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lung Neoplasms
  • Lysine
  • Mice
  • Models, Biological
  • Protein Binding
  • Protein Stability
  • Protein Transport
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Messenger
  • Subcellular Fractions
  • Survival Analysis
  • Ubiquitination
  • Ubiquitins